Skip to main content
OpenTrials

Clinical trial condition

Eczema, Atopic

Explore clinical trials studying Eczema, Atopic. Study availability and eligibility vary by location and protocol.

13 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Eczema, Atopic trial results

Recruiting

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

NCT07216027

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations
  • Northridge Clinical Trials Northridge, California, United States
  • Gsi Clinical Research Margate, Florida, United States
  • Skin Research of South Florida Miami, Florida, United States
  • Hattori Dermatology Clinic Takasaki, Gunma, Japan
View all 20 locations
View Trial Details
Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07599813

Conditions
Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • AllerVie Clinical Research Birmingham, Alabama, United States
  • Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
  • Saguaro Dermatology Associates Phoenix, Arizona, United States
  • Dermatology Trial Associates, Inc Bryant, Arkansas, United States
View all 85 locations
View Trial Details
Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

NCT06855745

Conditions
Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), +14 more
Locations
  • Canopy Clinical Northern Beaches Brookvale, New South Wales, Australia
  • Momentum Clinical Research Darlinghurst, New South Wales, Australia
  • Premier Specialists Kogarah, New South Wales, Australia
  • St George Dermatology Kogarah, New South Wales, Australia
View Trial Details
Completed

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

NCT06436183

Conditions
Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Medical Dermatology Specialists, PC/US Dermatology Partners Phoenix, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • First OC Dermatology Research, Inc. Fountain Valley, California, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
View all 35 locations
View Trial Details
Completed

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

NCT03568136

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
Locations
  • Klinische Forschung Dresden GmbH Dresden, Germany
  • Carl Gustav Carus University Hospital, Department of Dermatology Dresden, Germany
  • SRH Wald-Klinikum Gera, Center for Clinical Studies Gera, Germany
  • Hannover Medical School, Department for Dermatology, Allergy and Venereology Hanover, Germany
View Trial Details
Completed

A Study in Subjects With Moderate Atopic Dermatitis

NCT03175354

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Ralexar Investigational Site 35 Anniston, Alabama, United States
  • Ralexar Investigational Site 21 Birmingham, Alabama, United States
  • Ralexar Investigational Site 18 Laguna Hills, California, United States
  • Ralexar Investigational Site 23 Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

NCT03050151

Conditions
Atopic Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Fort Smith, Arkansas, United States
  • Regeneron Investigational Site Long Beach, California, United States
View all 37 locations
View Trial Details

Related conditions